MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas

被引：28
作者：
Abe, Hideaki [1 ]
Natsumeda, Manabu [1 ]
Kanemaru, Yu [1 ]
Watanabe, Jun [1 ]
Tsukamoto, Yoshihiro [1 ]
Okada, Masayasu [1 ]
Yoshimura, Junichi [1 ]
Oishi, Makoto [1 ]
Fujii, Yukihiko [1 ]
机构：
[1] Niigata Univ, Brain Res Inst, Dept Neurosurg, Niigata, Niigata, Japan
来源：
NEUROLOGIA MEDICO-CHIRURGICA | 2018年 / 58卷 / 07期
关键词：
MGMT; diffuse midline gliomas; Histone H3 mutation; resistance; epigenetics; INTRINSIC PONTINE GLIOMA; PEDIATRIC HIGH-GRADE; ADP-RIBOSE POLYMERASE; BRAIN-STEM; THERAPEUTIC TARGETS; K27M MUTATIONS; GLIOBLASTOMA; TUMORS; INHIBITOR; SUBGROUPS;
D O I：
10.2176/nmc.ra.2018-0044
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Histone H3 mutations are frequently found in diffuse midline gliomas (DMGs), which include diffuse intrinsic pontine gliomas and thalamic gliomas. These tumors have dismal prognoses. Recent evidence suggests that one reason for the poor prognoses is that O-6-methylguanine-DNA methyltransferase (MGMT) promoter frequently lacks methylation in DMGs. This review compares the epigenetic changes brought about by histone mutations to those by isocitrate dehydrogenase-mutant gliomas, which frequently have methylated MGMT promoters and are known to be sensitive to temozolomide.
引用
收藏
页码：290 / 295
页数：6
相关论文
共 49 条
  • [1] Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma
    Ahsan, Sama
    Raabe, Eric H.
    Haffner, Michael C.
    Vaghasia, Ajay
    Warren, Katherine E.
    Quezado, Martha
    Ballester, Leomar Y.
    Nazarian, Javad
    Eberhart, Charles G.
    Rodriguez, Fausto J.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [2] H3F3A K27M mutations in thalamic gliomas from young adult patients
    Aihara, Koki
    Mukasa, Akitake
    Gotoh, Kengo
    Saito, Kuniaki
    Nagae, Genta
    Tsuji, Shingo
    Tatsuno, Kenji
    Yamamoto, Shogo
    Takayanagi, Shunsaku
    Narita, Yoshitaka
    Shibui, Soichiro
    Aburatani, Hiroyuki
    Saito, Nobuhito
    [J]. NEURO-ONCOLOGY, 2014, 16 (01) : 140 - 146
  • [3] Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
    Banan, Rouzbeh
    Christians, Arne
    Bartels, Stephan
    Lehmann, Ulrich
    Hartmann, Christian
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2017, 5
  • [4] Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
    Bender, Sebastian
    Tang, Yujie
    Lindroth, Anders M.
    Hovestadt, Volker
    Jones, David T. W.
    Kool, Marcel
    Zapatka, Marc
    Northcott, Paul A.
    Sturm, Dominik
    Wang, Wei
    Radlwimmer, Bernhard
    Hojfeldt, Jonas W.
    Truffaux, Nathalene
    Castel, David
    Schubert, Simone
    Ryzhova, Marina
    Seker-Cin, Huriye
    Gronych, Jan
    Johann, Pascal David
    Stark, Sebastian
    Meyer, Jochen
    Milde, Till
    Schuhmann, Martin
    Ebinger, Martin
    Monoranu, Camelia-Maria
    Ponnuswami, Anitha
    Chen, Spenser
    Jones, Chris
    Witt, Olaf
    Collins, V. Peter
    von Deimling, Andreas
    Jabado, Nada
    Puget, Stephanie
    Grill, Jacques
    Helin, Kristian
    Korshunov, Andrey
    Lichter, Peter
    Monje, Michelle
    Plass, Christoph
    Cho, Yoon-Jae
    Pfister, Stefan M.
    [J]. CANCER CELL, 2013, 24 (05) : 660 - 672
  • [5] Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
    Buczkowicz, Pawel
    Bartels, Ute
    Bouffet, Eric
    Becher, Oren
    Hawkins, Cynthia
    [J]. ACTA NEUROPATHOLOGICA, 2014, 128 (04) : 573 - 581
  • [6] Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
    Castel, David
    Philippe, Cathy
    Calmon, Raphael
    Le Dret, Ludivine
    Truffaux, Nathalene
    Boddaert, Nathalie
    Pages, Melanie
    Taylor, Kathryn R.
    Saulnier, Patrick
    Lacroix, Ludovic
    Mackay, Alan
    Jones, Chris
    Sainte-Rose, Christian
    Blauwblomme, Thomas
    Andreiuolo, Felipe
    Puget, Stephanie
    Grill, Jacques
    Varlet, Pascale
    Debily, Marie-Anne
    [J]. ACTA NEUROPATHOLOGICA, 2015, 130 (06) : 815 - 827
  • [7] Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma
    Chassot, Andrea
    Canale, Sandra
    Varlet, Pascale
    Puget, Stephanie
    Roujeau, Thomas
    Negretti, Laura
    Dhermain, Frederic
    Rialland, Xavier
    Raquin, Marie Anne
    Grill, Jacques
    Dufour, Christelle
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (02) : 399 - 407
  • [8] Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
    Chheda, Zinal S.
    Kohanbash, Gary
    Okada, Kaori
    Jahan, Naznin
    Sidney, John
    Pecoraro, Matteo
    Yang, Xinbo
    Carrera, Diego A.
    Downey, Kira M.
    Shrivastav, Shruti
    Liu, Shuming
    Lin, Yi
    Lagisetti, Chetana
    Chuntova, Pavlina
    Watchmaker, Payal B.
    Mueller, Sabine
    Pollack, Ian F.
    Rajalingam, Raja
    Carcaboso, Angel M.
    Mann, Matthias
    Sette, Alessandro
    Garcia, K. Christopher
    Hou, Yafei
    Okada, Hideho
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 215 (01) : 141 - 157
  • [9] Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
    Chornenkyy, Yevgen
    Agnihotri, Sameer
    Yu, Man
    Buczkowicz, Pawel
    Rakopoulos, Patricia
    Golbourn, Brian
    Garzia, Livia
    Siddaway, Robert
    Leung, Stephie
    Rutka, James T.
    Taylor, Michael D.
    Dirks, Peter B.
    Hawkins, Cynthia
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (11) : 2560 - 2568
  • [10] Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
    Coulie, Pierre G.
    Van den Eynde, Benoit J.
    van der Bruggen, Pierre
    Boon, Thierry
    [J]. NATURE REVIEWS CANCER, 2014, 14 (02) : 135 - 146
12345